A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP, et al.
Nat Genet. 1995 May;10(1):111-3. doi: 10.1038/ng0595-111.
Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.
Borowczyk K, Piechocka J, Głowacki R, Dhar I, Midtun Ø, Tell GS, Ueland PM, Nygård O, Jakubowski H.
J Intern Med. 2019 Feb;285(2):232-244. doi: 10.1111/joim.12834. Epub 2018 Sep 23.
Inhibition of METTL3TAB3 m6A modifications via IGF2BP2-dependent mechanisms.
Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM.
Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709. Epub 2022 Apr 13.
[Bone quality].
Saito M, Marumo K.
Nihon Rinsho. 2015 Oct;73(10):1665-72.
Is renal function the key to disease risk management in elevated homocysteine levels?
Hirata A.
Hypertens Res. 2024 Jul;47(7):1976-1977. doi: 10.1038/s41440-024-01690-y. Epub 2024 May 15.
Role of homocysteine in end-stage renal disease.
Wu CC, Zheng CM, Lin YF, Lo L, Liao MT, Lu KC.
Clin Biochem. 2012 Nov;45(16-17):1286-94. doi: 10.1016/j.clinbiochem.2012.05.031. Epub 2012 Jun 6.
Vitamin B-12 malabsorption and renal function are critical considerations in studies of folate and vitamin B-12 interactions in cognitive performance: NHANES 2011-2014.
Samson ME, Yeung LF, Rose CE, Qi YP, Taylor CA, Crider KS.
Am J Clin Nutr. 2022 Jul 6;116(1):74-85. doi: 10.1093/ajcn/nqac065.
Quantification of urinary S- and N-homocysteinylated protein and homocysteine-thiolactone in mice.
Jakubowski H.
Anal Biochem. 2016 Sep 1;508:118-23. doi: 10.1016/j.ab.2016.06.002. Epub 2016 Jun 9.
Homocysteine and cardiovascular disease: cause or effect?
Brattström L, Wilcken DE.
Am J Clin Nutr. 2000 Aug;72(2):315-23. doi: 10.1093/ajcn/72.2.315.
Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease.
van Guldener C, Nanayakkara PW, Stehouwer CD.
Clin Chem Lab Med. 2007;45(12):1683-7. doi: 10.1515/CCLM.2007.340.
